Powerful cholesterol drug cuts heart attack risk by 31%
Budi Oetomo Narendra A groundbreaking study led by researchers from Mass General Brigham has revealed that the potent...
Breaking Oncology News & General Research
Groundbreaking MOMENTUM Study Reveals Hypercortisolism in Over Quarter of Resistant Hypertension Patients, Redefining Diagnostic Paradigms
The MOMENTUM study has delivered a significant revelation in cardiovascular medicine, identifying that a striking...
What’s hiding inside colon cancer could change treatment
Groundbreaking research from the University of East Anglia (UEA) has unveiled a surprising distinction in...
Bemnifosbuvir, a Hepatitis C Drug, Shows Potent Efficacy Against Hepatitis E, Offering Hope for a Neglected Global Health Threat
A drug currently undergoing clinical trials for the treatment of hepatitis C has demonstrated significant...
Scientists may have found a way to keep your bones strong for life
The persistent global challenge of osteoporosis, a debilitating condition characterized by weakened bones and increased...
Fred Hutch Researchers Unveil Groundbreaking Antibody Strategy to Block Epstein-Barr Virus, Paving Way for New Preventive Therapies.
SEATTLE, WA – In a significant scientific breakthrough with global health implications, researchers at the...
Rethinking Cancer Therapies: New Research Uncovers Why BET Inhibitors Fell Short and Points to a More Precise Future
For over a decade, the scientific community and pharmaceutical industry invested significant hope and resources...
University of Chicago Researchers Uncover Zeaxanthin’s Potent Role in Boosting Anti-Tumor Immunity, Enhancing Immunotherapy Efficacy
Researchers at the University of Chicago have made a groundbreaking discovery, revealing that zeaxanthin, a...
Pioneering Glyco-Immune Signatures to Revolutionize Aggressive Breast Cancer Diagnosis and Treatment
Breast cancer stands as the most commonly diagnosed cancer among women globally, presenting a formidable...
Genetic Differences May Limit Effectiveness of Widely Used Type 2 Diabetes Drugs, Stanford-Led Research Reveals
More than one in four individuals diagnosed with Type 2 diabetes currently utilize GLP-1 receptor...
